Please Wait...

LitTrace

Literature Monitoring Tool

LitTrace is a customizable literature monitoring and tracking tool that ensures timely access to reliable and consolidated information on relevant safety-related literature and creates databases for ICSR's and similar compliance reports.

LitTrace can be used to monitor literature relating to:

  • Clinical evaluation
  • Pre-market approval
  • Adverse events reporting

Benefits of LitTrace include:

  • Fully customizable – per client's unique requirements
  • Flexible folder structure – build multiple folders based on product or therapeutics areas (including subfolders)
  • Import third party data – EMBASE, MEDLINE, etc.
  • Simple, easy-to-use tool – for assessment workflow tracking
  • Configurable reporting engine
  • Flexible delivery options – client environment or Bioclinica hosted
  • Central repository – for weekly hits and full-text articles
  • One-stop solution to track full-text article – translation and contract author requests preparation and compliance as required by the FDA, EMEA and other global regulatory bodies

Download our info sheet

ADDITIONAL RESOURCES

LitTrace and PVTrace

Download Info Sheet

Meet the Bioclinica Safety and Regulatory Team: Sukrit Singh, Engagement Manager

Read Blog

Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Great advice from our Dir. Cardiovascular Imaging on how to achieve top quality imaging acquisitions & assessments… https://t.co/P57970FrOf
bioclinica (18 hours ago)
RT @CenterWatch: #CWWeekly: The increasing trend of adopting digital health and #mhealth apps for patient care. Read more, https://t.co/wo9…
bioclinica (19 hours ago)
RT @CenterWatch: Examining the difference between #patient engagement & patient recruitment. Read more in #CWPulse by @AshleyTointon, https…
bioclinica (19 hours ago)
RT @CenterWatch: How can #socialmedia play a role in health disparities and #clinicaltrial patient recruitment? Read more in #CWPulse by @A…
bioclinica (19 hours ago)
RT @RAPSorg: What New @FDAcdrhIndustry Guidance is Coming in FY 2018: Alternative 510(k) Pathway and More | #Regulatory Recon https://t.co/…
bioclinica (19 hours ago)
RT @RAPSorg: .@US_FDA Finalizes Guidance on Promotional Drug Labeling and Ads | #Regulatory Focus https://t.co/2rmtTWajlf #FDA #pharma
bioclinica (19 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices